The Group...
Ishita Drugs & Industries Limited is the flagship company of
the 'Ishita' Group, which is a respected member of the Indian Business
community for more than 3 decades. The Group's interests encompass
manufacture of a large number of Bulk Actives and their salts, Drug
Intermediates, Fine Chemicals, Food additives, Specialty/ Performance
Chemicals, Pharmaceutical formulations, healthcare products, dyes
and dye intermediates, distribution of financial products and other
businesses. The Ishita Group derives its key strengths from its
strong ethical practices and moral values in business commitments.
The Company...
Ishita Drugs & Industries Limited is a public limited company,
listed on the local stock exchanges (BSE and ASE) in India. Incorporated
in 1992, the company has earned a reputation as a "high quality
manufacturer" in a very short time.
IDIL is engaged in the manufacture of various Active Pharma Ingredients
(bulk actives and their salts), bulk drug intermediates, excipients
and fine chemicals. It has a state-of-art manufacturing facility,
in terms of chemical synthesis, quality control and environmental
safety.
The People
The vision and the strategy of the company is formulated by the
Board of Directors, which comprises independent, highly qualified
professionals for various fields.
IDIL is headed by Mr. Jagdish Agrawal, Managing Director,
who is a M.S (Chemical Technology) from University of Florida, USA.
He has more than 30 years experience in the chemical and pharmaceutical
industry and is widely acknowledged as an expert in his field. He
has earlier been associated with very successful ventures in the
reactive dye industry and in the bulk drug industry.
The Head of Operations is Mr. Kiran Rindani, M. Tech (Chemical
Technology) from U.D.C.T., Mumbai University, Mumbai. He has about
25 years of experience and has worked with Lupin Laboratories, Unimark
etc. before joining this company.
The Mission...
Ishita Drugs and Industries Ltd. has been incorporated with a philosophy
to "provide quality drugs in the service of humanity worldwide."
The growing global population demands a continuous advancement
in the treatment of disease to alleviate human suffering necessitating
a need for newer & safer drugs.
It is the mission of Ishita Drugs to contribute in this noble endeavour
by producing high quality pharmaceutical drugs and to engage in
research for newer molecules and by doing so, "to become a
global player in healthcare business".
|